¼¼°èÀÇ ÀÏȸ¿ë ³»½Ã°æ ½ÃÀå ±Ô¸ð´Â 2024-2032³â¿¡ CAGR 14.1%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ȯÀÚÀÇ ¾ÈÀü°ú ÆíÀǼº Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÷´Ü À̹Ì¡ ¹× ¹«¼± ¼³°è¿Í °°Àº ÀÏȸ¿ë ³»½Ã°æ ±â¼ú Çõ½ÅÀÌ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ·¯ÇÑ ¹ßÀüÀº °¨¿° °ü¸® ¹× »ç¿ë ÆíÀǼº°ú °°Àº Áß¿äÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ°í ±âÁ¸ÀÇ Àç»ç¿ë °¡´ÉÇÑ Àåºñ¿¡ ºñÇØ ´õ ¾ÈÁ¤ÀûÀ̰í À§»ýÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ ¾ÈÀü°ú ¾÷¹« È¿À²¼ºÀ» Á¡Á¡ ´õ ¿ì¼±½ÃÇÔ¿¡ µû¶ó ÷´Ü ±â¼ú°ú ÆíÀǼº ¹× ¾ÈÀü¼º Çâ»óÀ» °áÇÕÇÑ ÀÏȸ¿ë ³»½Ã°æ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹¸¦ µé¾î 2022³â 11¿ù Integrated Endoscopy´Â °üÀý°æ ¼ö¼ú¿¡¼ ±âÁ¸ Àç»ç¿ë °¡´ÉÇÑ °üÀý°æÀÇ ÇѰ踦 ±Øº¹Çϱâ À§ÇØ ¼³°èµÈ ¹èÅ͸® ±¸µ¿, ¹«¼±, ÀÏȸ¿ë 2¼¼´ë NUVIS °üÀý°æÀ» ¹ßÇ¥Çß½À´Ï´Ù. À̹ø °³¹ßÀº ÀÏȸ¿ë ³»½Ã°æ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÏ´Â Çõ½ÅÀûÀÌ°í »ç¿ëÀÚ Ä£ÈÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Ãß¼¼¸¦ Àß º¸¿©ÁÝ´Ï´Ù. À̴ ÷´ÜÀ̰í À§»ýÀûÀ̸ç È¿À²ÀûÀÎ ³»½Ã°æ ±â¼ú·Î ½ÃÀå º¯È¸¦ ¹Ý¿µÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ³»½Ã°æ ±â¼úÀÇ Ã¤Åðú ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
ÀÏȸ¿ë ³»½Ã°æ »ê¾÷Àº Á¦Ç°, ¿ëµµ, ȯÀÚ À¯Çü, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªº°·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù.
½ÊÀÌÁöÀå ³»½Ã°æÀº ƯÈ÷ ½ÊÀÌÁöÀå Áø´Ü ¹× Ä¡·á¿Í °°Àº ¼ÒȰü ½Ã¼ú¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇϹǷΠ2032³â±îÁö Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¼Òȱâ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³»½Ã°æ ½Ã¼ú½Ã °¨¿° °ü¸®ÀÇ Çʿ伺ÀÌ ÀÏȸ¿ë ½ÊÀÌÁöÀå ³»½Ã°æ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë µðÀÚÀÎÀº ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» Å©°Ô ÃÖ¼ÒÈÇϰí ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ã۱⠶§¹®¿¡ ÀÇ·á ȯ°æ¿¡¼ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. °¨¿° ¿¹¹æ°ú ½Ã¼úÀÇ È¿À²¼ºÀÌ ÀÌ ºÎ¹®ÀÇ ¿ìÀ§¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.
±â°üÁö°æ ºÎ¹®Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °¨¿° °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó 2032³â±îÁö »ó´çÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÏȸ¿ë ±â°üÁö°æÀº È£Èí±â Áúȯ °ü¸®¿¡ ÇʼöÀûÀΠȯÀÚ °£ ÀÌÂ÷ ¿À¿°À» ¹æÁöÇÏ´Â Áß¿äÇÑ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀÏȸ¿ë ¼³°è´Â ³ôÀº À§»ý ¼öÁØÀ» º¸ÀåÇÏ°í º´¿ø³» °¨¿° À§ÇèÀ» ÁÙÀ̱⠶§¹®¿¡ ÀÓ»ó ÇöÀå¿¡¼ ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ ¾ÈÀü°ú È¿À²¼º¿¡ ´ëÇÑ °Á¶´Â ±â°üÁö°æ ºÎ¹®ÀÇ Å« ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.
À¯·´Àº ÷´ÜÈµÈ ÀÇ·á ÀÎÇÁ¶ó, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ, ³ôÀº Çõ½Å ÀÇ·á ±â¼ú äÅ÷ü¿¡ ÈûÀÔ¾î 2024-2032³â ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼´Â °¨¿° ¹æÁö¿Í ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ±³Â÷ ¿À¿° À§ÇèÀ» ÁÙÀÌ°í ½Ã¼ú È¿À²À» Çâ»ó½ÃŰ´Â ÀÏȸ¿ë ³»½Ã°æ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯·´ÀÇ ÅºÅºÇÑ ÀÇ·á ½Ã½ºÅÛ°ú ÁÖ¿ä ÀÇ·á±â±â Á¦Á¶¾÷üÀÇ °·ÂÇÑ ÀÔÁö´Â ¼¼°è ÀÏȸ¿ë ³»½Ã°æ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
Global Disposable Endoscopes Market size will expand at a 14.1% CAGR between 2024 and 2032, fueled by innovations in disposable endoscope technology, such as advanced imaging and cordless designs, along with a focus on enhancing patient safety and convenience. These advancements address critical issues like infection control and ease of use, offering more reliable and hygienic solutions compared to traditional reusable devices. As healthcare providers increasingly prioritize patient safety and operational efficiency, the demand for disposable endoscopes that combine cutting-edge technology with enhanced convenience and safety will grow, fueling market expansion.
For instance, in November 2022, Integrated Endoscopy introduced the second-generation NUVIS arthroscope, a battery-operated, cordless, single-use device designed to overcome the limitations of conventional reusable arthroscopes in arthroscopic surgeries. The development highlights a trend toward innovative, user-friendly solutions that cater to the growing demand for disposable endoscopes. It reflects the market's shift towards advanced, hygienic, and efficient endoscopic technologies, driving further adoption and growth.
The disposable endoscopes industry is fragmented based on product, application, patient type, end-use, and region.
The duodenoscopes segment will experience a substantial surge by 2032, attributed to their critical role in gastrointestinal procedures, particularly for diagnosing and treating conditions in the duodenum. The rising prevalence of gastrointestinal diseases and the need for infection control in endoscopic procedures drive demand for disposable duodenoscopes. Their single-use design greatly minimizes the risk of cross-contamination and improves patient safety, making these devices a favored option in healthcare environments. The focus on infection prevention and procedural efficiency supports the dominance of this segment.
The bronchoscopy segment will achieve a considerable foothold by 2032, owing to the increasing prevalence of respiratory diseases and the growing emphasis on infection control. Disposable bronchoscopes offer a critical advantage in preventing cross-contamination between patients, which is essential in managing respiratory conditions. Their single-use design ensures high hygiene standards and reduces the risk of nosocomial infections, making them highly valued in clinical settings. This focus on patient safety and efficiency drives the substantial growth of the bronchoscopy segment.
Europe will record a remarkable growth rate from 2024 to 2032, propelled by its advanced healthcare infrastructure, stringent regulatory standards, and high adoption rates of innovative medical technologies. The region's emphasis on infection control and patient safety drives the demand for disposable endoscopes, which reduce the risk of cross-contamination and improve procedural efficiency. Additionally, Europe's well-established healthcare systems and strong presence of leading medical device manufacturers make it a primary contributor to the global disposable endoscopes market.